US Approvals Analysis: Drug-Coated Balloon, Valve Tech Are July Highlights
July was a relatively light month for novel-device approvals by US FDA, but year-to-date volumes remain strong. Spotlighted devices include approval of a new drug-coated balloon and heart valve devices. Here's a roundup from Medtech Insight's Approval Tracker.
You may also be interested in...
Four-year data from the COMMENCE trial of surgical valves made of Resilia bovine pericardial tissue showed no early or late structural valve deterioration or valve thrombosis.
Edwards LifeScience’s Intuity Elite and LivaNova’s Perceval sutureless valves were granted a $6,000 new technology hospital inpatient add-on payment for fiscal 2018.
In its second acquisition this month and fourth this year, Philips is buying US device maker Spectranetics Corp. for about $2bn to add laser atherectomy catheters to its vascular imaging line-up.